Profile data is unavailable for this security.
About the company
Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. It specializes in blood volume measurement technology focused on blood volume testing innovation. It markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. It has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.
- Revenue in USD (TTM)66.31k
- Net income in USD1.80m
- Incorporated1971
- Employees37.00
- LocationDaxor Corp107 Meco LaneOAK RIDGE 37830United StatesUSA
- Phone+1 (865) 425-0555
- Fax+1 (212) 244-0806
- Websitehttps://www.daxor.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IB Acquisition Corp | 0.00 | 2.45m | 61.65m | -- | 70.32 | 2.99 | -- | -- | 0.1527 | 0.1527 | 0.00 | 3.59 | 0.00 | -- | -- | -- | 3.57 | -- | 3.62 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 82.94 | -- | -- | -- |
| A SPAC II Acquisition Corp | 0.00 | -224.48k | 64.07m | 2.00 | -- | -- | -- | -- | -0.0409 | -0.0409 | 0.00 | -1.33 | 0.00 | -- | -- | -- | -8.59 | -- | -10.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -244.77 | -- | -- | -- |
| Ribbon Acquisition Corp | 0.00 | 569.30k | 64.21m | -- | 112.91 | 0.2687 | -- | -- | 0.0938 | 0.0938 | 0.00 | 39.42 | 0.00 | -- | -- | -- | 2.20 | -- | 2.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Mount Logan Capital Inc | 488.01k | 2.98m | 65.85m | 7.00 | 17.26 | 1.07 | 22.03 | 134.94 | 0.2984 | 0.2984 | 0.0488 | 4.80 | 0.0101 | -- | -- | -- | 6.16 | -11.61 | 6.35 | -11.88 | -- | -- | 611.53 | -715.18 | -- | -- | 0.00 | -- | 254.26 | -26.33 | 71.72 | -- | -- | -- |
| Daxor Corp | 66.31k | 1.80m | 66.31m | 37.00 | 27.87 | 1.59 | -- | 1,000.06 | 0.4084 | 0.4084 | 0.0133 | 7.15 | 0.0019 | -- | 4.20 | -- | 5.12 | 6.84 | 5.26 | 7.28 | -1,927.96 | -365.37 | 2,710.68 | 854.81 | -- | -- | 0.0073 | -- | -26.75 | -20.63 | 91.11 | -- | -- | -- |
| International Media Acquisition Corp | 0.00 | -199.50k | 66.79m | -- | -- | -- | -- | -- | -0.0291 | -0.0291 | 0.00 | -1.72 | 0.00 | -- | -- | -- | -2.57 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 49.89 | -- | -- | -- |
| Great Elm Group Inc | 22.62m | -13.71m | 66.80m | 50.00 | -- | 1.14 | -- | 2.95 | -0.6904 | -0.6904 | 0.5698 | 1.79 | 0.1651 | -- | 6.13 | 452,320.00 | -9.66 | 0.1617 | -10.73 | 0.1921 | 31.00 | 32.78 | -58.50 | 1.17 | -- | -10.54 | 0.5104 | -- | -8.51 | -22.67 | 1,018.16 | -- | -12.59 | -- |
| MFS Investment Grade Municipal Trust | -100.00bn | -100.00bn | 67.48m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Piermont Valley Acquisition Corp | 0.00 | -372.89k | 67.86m | -- | -- | 47.07 | -- | -- | -0.0772 | -0.0772 | 0.00 | 0.2422 | 0.00 | -- | -- | -- | -4.53 | -- | -5.36 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.18 | -- | -- | -- |
| Invesco High Income Trust II | -100.00bn | -100.00bn | 70.83m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 47.98k | 0.82% |
| Renaissance Technologies LLCas of 31 Dec 2025 | 28.22k | 0.48% |
| Nano-Cap New Millennium Advisors LLCas of 31 Dec 2025 | 12.50k | 0.22% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 3.24k | 0.06% |
| SBI Securities Co., Ltd.as of 31 Dec 2025 | 3.13k | 0.05% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 1.05k | 0.02% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2025 | 500.00 | 0.01% |
| UBS Securities LLCas of 31 Dec 2025 | 90.00 | 0.00% |
| JPMorgan Securities LLC (Investment Management)as of 31 Dec 2025 | 5.00 | 0.00% |
| BofA Securities, Inc.as of 31 Dec 2025 | 0.00 | 0.00% |
